Будь ласка, зачекайте, ми завантажуємо дані графіка
AbbVie Inc спільнота
About AbbVie Inc
What is AbbVie Inc?
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
The current price of AbbVie Inc in the market is 11 607,74 ₴, with a 24-hour trading volume of 42,06B ₴. The asset's market cap is 20,5T ₴, after moving -0.94% in the last day.
Tokenized AbbVie Inc is trading at 11 883,26 ₴, with a tokenized market cap of 2,65B ₴ and a 24-hour trading volume of 60,08M ₴. The tokenized asset has moved 2.36% in the past 24 hours.